All Stories

  1. Harnessing Nanoemulsions for Tailored Breast Cancer Therapy: Recent Insights and Opportunities
  2. Mechanistic Insights into the Anticancer Potential of Echinacoside: Therapeutic Applications and Future Directions
  3. Animal Models of Traumatic Brain Injury and Their Relevance in Clinical Settings
  4. Emerging phytochemical-based nanocarriers: redefining the perspectives of breast cancer therapy
  5. Polypharmacology and Neuroprotective Effects of Gingerol in Alzheimer’s Disease
  6. Unlocking the Neuroprotective Potential of Silymarin: A Promising Ally in Safeguarding the Brain from Alzheimer’s Disease and Other Neurological Disorders
  7. Revolutionizing Parkinson’s treatment: Harnessing the potential of intranasal nanoemulsions for targeted therapy
  8. Diverse models in Alzheimer's research: exploring alternative approaches beyond traditional rodent frameworks
  9. Unveiling the Involvement of Herpes Simplex Virus-1 in Alzheimer’s Disease: Possible Mechanisms and Therapeutic Implications
  10. Investigating the Potential Therapeutic Mechanisms of Puerarin in Neurological Diseases
  11. Targeting brain tumors with innovative nanocarriers: bridging the gap through the blood-brain barrier
  12. Measuring dopamine in rodent brain tissue by using UHPLC-Xevo-TQD triple quadrupole mass spectrometry: A comparative influence of selegiline nanoemulsion administered intranasally over solution on upregulation of dopamine level
  13. Screening of surfactant mixture ratio for preparation of oil-in-water nanoemulsion: A technical note
  14. Unveiling Therapeutic Targets: Targeting Mitochondrial ROS for Anticancer Therapy
  15. Potential of nanoemulsions for accelerated wound healing: innovative strategies
  16. Insights on prospective role of Gallic acid as a Bioavailability Enhancer
  17. Caenorhabditis elegans as a model system to evaluate neuroprotective potential of nano formulations
  18. Mechanistic Insights into the Pharmacological Significance of Silymarin
  19. New insights into quercetin nanoformulations for topical delivery
  20. Synthesis, Molecular Docking, and Biological Evaluation of Some Novel 2-(5-Substituted 1,3,4-oxadiazole-2-yl)-1,3-benzothiazole Derivatives as Anticonvulsant Agents
  21. Ethnopharmacological perspectives of glucokinase activators in the treatment of diabetes mellitus
  22. A review on liquid chromatographic methods for the bioanalysis of atorvastatin
  23. In-silico molecular docking study of some n-substituted thiazoles derivatives as FabH inhibitors
  24. Development and validation of HPLC-UV based bioanalytical method for the quantification of atorvastatin in rat plasma
  25. Molecular docking of some benzothiazoles derivatives as anticonvulsant agents